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Elucidating the adaptive strategies and plasticity of bacterial genomes in situ is crucial for
understanding the epidemiology and evolution of pathogens threatening human health.
While much is known about the evolution of Escherichia coli in controlled laboratory
environments, less effort has been made to elucidate the genome dynamics of E. coli in
its native settings. Here, we follow the genome dynamics of co-existing E. coli lineages
in situ of the infant gut during the first year of life. One E. coli lineage causes a urinary
tract infection (UTI) and experiences several alterations of its genomic content during
subsequent antibiotic treatment. Interestingly, all isolates of this uropathogenic E. coli
strain carried a highly stable plasmid implicated in virulence of diverse pathogenic strains
from all over the world. While virulence elements are certainly beneficial during infection
scenarios, their role in gut colonization and pathogen persistence is poorly understood.
We performed in vivo competitive fitness experiments to assess the role of this highly
disseminated virulence plasmid in gut colonization, but found no evidence for a direct
benefit of plasmid carriage. Through plasmid stability assays, we demonstrate that this
plasmid is maintained in a parasitic manner, by strong first-line inheritance mechanisms,
acting on the single-cell level, rather than providing a direct survival advantage in the gut.
Investigating the ecology of endemic accessory genetic elements, in their pathogenic
hosts and native environment, is of vital importance if wewant to understand the evolution
and persistence of highly virulent and drug resistant bacterial isolates.
Keywords: Escherichia coli, genome evolution, virulence plasmid dynamics, plasmid persistence, horizontal gene
transfer, antibiotic treatment, urinary tract infections, infant gut
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INTRODUCTION
The human gut is home to a dense microbial ecosystem, the
human gut microbiota, playing an important role in human
health and physiology (Marchesi et al., 2015). As a commensal
constituent of the gut microbiota in warm-blooded animals,
Escherichia coli is highly adapted to the gut and colonizes the
gastrointestinal tract within the first hours of life (Drasar and
Hill, 1974). However, some environmental and commensal E.
coli isolates have acquired genetic factors that allow them to
cause disease within the digestive tract or when transferred to
other body sites such as the blood, brain, and urinary tract
(Smith et al., 2007). While diarrheagenic E. coli are a common
cause of gastro intestinal infections in third world countries
and travelers, extraintestinal pathogenic E. coli (ExPEC) are
facultative pathogens that reside in the human gut microbiota but
occasionally establish in extra-intestinal body sites (Köhler and
Dobrindt, 2011). Here, urinary tract infections casued by ExPEC
are among the most common bacterial infections in developed
countries, were patients are often infected via transmission of
strains from their own intestinal flora to their urinary tract
(Foxman, 2010).
The broad adaptation of E. coli to the gut environment
and extraintestinal body sites is reflected in the remarkable
genetic diversity within the species. This genetic flexibility is
largely facilitated by horizontal gene transfer (HGT) of accessory
genetic elements including plasmids and phages (Brzuszkiewicz
et al., 2009). These elements are widely present within the
gut microbiota and can provide their bacterial hosts with
antibiotic resistance or virulence factors (Salyers et al., 2004;
Sommer et al., 2010). Acquiring virulence genes might not
only influence the risk and severity of infections caused by the
pathogen, but has also been suggested to assist in the general
persistence of commensal bacterial strains of the gut (Diard
et al., 2010; Chen et al., 2013). Indeed, virulence determinants
such as those involved in adhesion, biofilm formation and
iron acquisition correlate with prolonged colonization in the
digestive tract (Adlerberth et al., 1998; Nowrouzian et al.,
2003).
Recent studies into the dynamics of clinical bacterial genomes
at genomic resolution have been carried out with time-series
sampling and underlines the high plasticity of plasmids and their
host associations in situ (Conlan et al., 2014, 2016). Conjugative
plasmids are of particular interest, as they are the main vehicles
of HGT in E. coli, playing an essential role in the adaptation
toward antibiotics or specific host niches (Johnson and Nolan,
2009; Norman et al., 2009).
Whereas, much effort has been devoted to study the survival
conditions of plasmids in vitro (Slater et al., 2008) our knowledge
on the behavior of plasmids in situ of their native hosts and
natural environment is limited (Karami et al., 2007; Conlan et al.,
2014, 2016). In order for a plasmid to persist in the long term,
it needs to either be stably segregated upon cell division, confer
a fitness advantage to its host, or transfer at high enough rates
to compensate the lack of the latter two (Simonsen, 1991; Slater
et al., 2008). As most plasmids do not exhibit sufficient rates
of transfer to survive without selection, stable inheritance, and
adaptive traits are key to their long term survival (Simonsen,
1991).
To elucidate the genome dynamics of E. coli in its native
environment of the gut, we genome sequenced individual E. coli
isolates over the first year of an infant’s life. We conduct in vitro
and in vivo competition assays to elucidate the selective drivers
of the observed dynamics, and gain a deeper understanding of
the endemic mobile elements contributing to the dissemination
of virulence and antibiotic resistance factors.
MATERIALS AND METHODS
Genome Sequencing of E. coli Lineages
The strains were isolated and typed as part of a previous study
by Karami et al. (2007). These were cultured in LB broth and
genomic DNA was isolated using an UltraClean© Microbial
DNA Isolation Kit (MoBio Laboratories, Inc., California).
Sequencing libraries were prepared using the TruSeq andNextera
XT (Illumina, California) protocols. Illumina HiSeq sequencing
was performed by Partners HealthCare Center for Personalized
Genetic Medicine (Cambridge, Massachusetts).
Sequence Analysis
Genomes for each sequenced isolate were assembled using Velvet
(v1.2.10; Zerbino and Birney, 2008) and annotated via RAST
(Aziz et al., 2008). Reads from the isolates were mapped onto
the reference, e.g., earliest isolated, genome via Bowtie2 (2.1.0;
Langmead et al., 2009), and single nucleotide polymorphisms
(SNPs) were enumerated via SAMTools (0.1.19; Li et al., 2009).
The SNP threshold was set to include SNPs with a phred score
of above 30 and at least 90% of the high-quality reads at
the site as the variant. Additionally, to ensure that all isolates
within a lineage consisted of the same genomic content as
the representative isolates, genomic areas lacking mapped read
coverage were identified using BEDTools (2.18.2; Quinlan and
Hall, 2010).
The pNK29 plasmid was assembled into a circular plasmid
with aid from plasmid alignments produced using MUMer
(Kurtz et al., 2004). Contigs belonging to the pNK29 antibiotic
resistance plasmid were first identified in lineage B as the new
genetic material of the isolate at 32 days, and then used to identify
the corresponding contigs in the lineage A genome. The RAST
annotations for this plasmid were refined based on homologous
genes in pOLA52 (NC_010378.1) that were either missing or
incorrect in pNK29.
Plasmid Identification and Comparison
Other plasmids were identified by first separating contigs based
coverage to infer copy-number relative to genomic contigs and
then by grouping contigs together with similar abundances.
The average coverage of each contig was determined using
BEDTools (Quinlan and Hall, 2010). Plasmid incompatibility
grouping was done using the PlasmidFinder tool (Carattoli
et al., 2014). Homologous previously sequenced plasmids were
identified using BLAST and the NCBI nt database (Altschul et al.,
1990). Circular plasmid diagrams were created using the BLAST
ring image generator (BRIG; Alikhan et al., 2011).
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For pNK29-2, blastn searches of the plasmid contigs revealed
14 plasmids with very high identity (99%) and hits with a pNK29-
2 coverage of >97% where selected (Figure 3 and Table S4).
As an exception, pECO-bc6 was also included despite its lower
coverage (88%) to illustrate deletion of plasmid accessory genes
flanked by inverted repeats. The EasyFigure software was used
for linear comparison of plasmid sequences displayed in Figure 4
(Sullivan et al., 2011).
The core genome of the E. coli hosts listed in Figure 3
was estimated using ROARY via annotations from PROKKA
(Seemann, 2014; Page et al., 2015). The aligned, ungapped
core genome was used to construct a maximum likelihood
phylogenetic tree using the RAxML software (Stamatakis, 2014).
MLST types were assigned usingMLSTfinder (Larsen et al., 2012),
and fimH types were assigned using the sequences referred to by
Dias et al. (2010).
Strain Tagging and pNK29-2 Plasmid
Curing
Lineage A and B strains isolated at the first time point were tagged
with antibiotic resistance markers to allow quantification during
competitive fitness experiments, plasmid loss experiments,
assessment of conjugation ability, and plasmid curing. Resistance
cassettes conferring resistance to Chloramphenicol and
Kanamycin respectively were amplified from cloning vectors
of the pZ system (Lutz and Bujard, 1997) and inserted into the
chromosomal araB gene of the Lineage A and B strains using the
Lambda Red recombineering system of pTKRED (Kuhlman and
Cox, 2010). The following regions of homology were used for
insertions into araB: 5′-GTAGCGAGGTTAAGATCGGTAATC
ACCCCTTTCAGGCGTTGGTTAGCGTT-3′ and 5′-GCCTAA
CGCACTGGTAAAAGTTATCGGTACTTCCACCTGCGACA
TTCTGA-3′.
The pNK29-2 plasmid was tagged with the Sh ble Zeocin
resistance gene in a transposase gene located at 61 kb using the
following homology ends: 5′-CTTCGGGAACGCTGTAACGAT
TACCACCAACCTCGATATAGCTGTCCCGG-3′ and 5′-TAA
CAACGGGAAAGTCGTGTTCAACTCCGGATTCCTGTTGC
TGGCCGACC-3′.
To cure pNK29-2 we disrupted the stbA gene of the stbAB
stability operon with a Kanamycin resistance marker using
the following homology ends: 5′-CATAAATGTGATGTGT
GAAGTATGATGATATTTTGACACGGTAACCTGAGTA
GGGATAACAGGGTAAT-3′ and 5′-TTCATTTTAAGAC
GCACATCATTCATTGCCTCCTGCACCGAATCAGTAG
CTAGGGATAACAGGGTAAT-3′. These contain the 18 bp
I-SceI endonuclease site enabling in situ double digestion
of the recombinant plasmid to enhance plasmid loss via
induction of the I-SceI endonuclease from pTKRED. Following
recombineering, recombinants were selected on Kanamycin
containing plates incubated at 30◦C to retain the pTKRED
plasmid. These were verified with PCR to confirm insertion
into the stbA gene. Verified colonies were inoculated directly
into LB medium containing 0.5% w/v L-arabinose and grown
at 30◦C for 2 h to induce expression of the pTKRED encoded
I-SceI endonuclease and subsequently switched to 42◦C for
3 h to allow curing of the temperature sensitive pTKRED
vector. The culture was diluted and plated on LB to obtain
single colonies that were confirmed for plasmid curing by the
absence of growth on Kanamycin (pNK29-2) and Spectinomycin
(pTKRED). The curing of pNK29-2 was validated by PCR using
primers targeting two distinct loci of the pNK29-2 backbone:
Upstream stb: 5′-CTCAACAAGGGTTATTGC-3′, downstream
stb: 5′-GAATGGCAAATGAAACG-3′ and Upstream 61 kb
transposase: 5′-GAATGGCAAATGAAACG-3′, downstream 61
kb transposase: 5′-AGAAGGCTGCGGTGCTGAAG-3′. The
plasmid-cured variant of the lineage A strain was re-transformed
with the Zeocin tagged pNK29-2 plasmid to control for potential
effects of the curing process.
Conjugative Transfer Assessment
In order to test the ability of pNK29-2 to conjugate, outgrown
over-night (O/N) cultures as well as exponentially growing
cultures of the lineage A strain and E. coli MG1655::tetA was
mixed equally and incubated O/N. Incubations were done at
37◦C and 30◦C on a solid agar surface as well as in liquid cultures
without shaking. Additional tagging at the 32 and 26 kb positions
were carried out to ensure that the initial insertion at the 61
kb position of pNK29-2 was not the cause of the dysfunctional
conjugation ability.
In vitro Competition, Growth Rate, and
Plasmid Loss Assays
Two O/N cultures were diluted to the same OD and mixed
1:1 in LB medium. The competition was carried out in 1.5
ml cultures and a volume of 1.5 µl was transferred to a
fresh well every 20 h. From OD measurements the number of
generations was estimated to∼10 generations/transfer. The ratio
of the competitors was determined as the fraction of colonies
on Chloramphenicol agar plates compared to plates containing
Kanamycin. Plasmid loss was assessed by comparing plate-counts
of at least 100 colonies on LB and Zeocin agar plates. In addition,
colonies from LB plates were streaked on Zeocin containing
plates and PCR (using the primers listed in the plasmid curing
section) was performed on a subset of colonies to verify plasmid
presence. Competitions in iron-limited medium was carried out
as for the LB competitions described above, except that M9
medium [M9 minimal medium (standard), 2010] with 5 µM
FeCl3 was used instead or LB. OD measurements of growth
rates in M9 5 µM FeCl3 were conducted in 96-well plates
containing 150 µl medium/well using a ELx808 plate reader
(BioTek, USA). Breathe-Easy (Sigma-Aldrich) film was applied
to minimize evaporation during measurements. OD at 600 nms
was measured with 5-min intervals for 24 h and incubated with
shaking at 37◦C between measurements.
In vivo Competition Experiments
Female BALB/c mice (5–6 weeks old) were used in all in vivo
studies (Charles River Laboratories, distributed by Scanbur).
All mice were pre-treated orally with streptomycin as described
previously (Lasaro et al., 2014). Briefly, streptomycin sulfate salt
(Sigma-Aldrich) was added to the drinking water at 5 g/L, along
with 5 g/L of glucose, to enhance taste, for 72 h followed by 24
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h of fresh water (no drug or glucose) to allow the streptomycin
to clear the animal’s system prior to infection. A single colony of
each E. coli strain was grown in LB shaking overnight at 37◦C.
Cells were pelleted, washed once in PBS and re-suspended in
PBS (13 mM phosphate with 137 mM NaCl at pH 7.4), and then
mixed in a 1:1 ratio of E. coli lineage A isolate with pNK29-
2 to the cured variant. Fifteen mice that were pre-treated with
streptomycin followed by 24 h without drug were administered
100 µL containing 2× 108 CFU of this 1:1 E. colimixture by oral
gavage. Feces was collected at days 2, 4, 7, and 12 post-infection.
Additionally, on day 12 following termination of the experiment,
a segment of the small intestine was removed. The feces and
small intestine segment were homogenized in PBS, serially
diluted, and equal amounts were plated on LA-Cam (25 µg/ml
chloramphenicol, selecting for the pNK29-2 containing strain)
and LA-Kan (50µg/ml kanamycin, selecting for the cured strain).
Following overnight incubation at 37◦C, CFUs were enumerated
and subsequently replica plated from both LA-Cam and LA-
Kan to LA-Zeo (40 ug/ml zeocin) to screen for the presence and
transfer of the pNK29-2 plasmid containing a Zeocin-resistance
marker. CFU values were normalized per gram of tissue (CFU/g).
The competitive index was calculated by dividing the OUTPUT
on days 2, 4, 7, and 12 (CamR CFU/g divided by KanR CFU/g)
by the INPUT on day 0 (CamR CFU/g divided by KanR CFU/g).
The input value was 1.04 indicating a 1:1.04 initial ratio of E.
coli lineage A isolate with pNK29-2 relative to the cured E.
coli lineage A isolate. The non-parametric Mann-Whitney U-
Test was used to compare the sample populations. The P-values
indicate the probability of falsely rejecting the null-hypothesis of
equal population means.
Ethics Statement
Animal experiments were performed in accordance with national
(regulation SJVFS 2012:26) and institutional guidelines. The
Uppsala Animal Experiments Ethics Review Board in Uppsala,
Sweden approved all mouse protocols undertaken in this study
under reference no. 154/14. Animal experiments were performed
at the Swedish National Veterinary Institute (SVA) in Uppsala,
Sweden.
RESULTS
The current study material was obtained from an infant enrolled
in the ALLERGYFLORA study with the original purpose of
correlating the composition of the gut microbiota to the
development of allergies later in life (Adlerberth et al., 2006).
This infant was subjected to long-term antibiotic treatment as
a consequence of a urinary tract infection, and was selected for
this study due to an observed change in the resistance profile of
E. coli strains isolated from this infant (Karami et al., 2007).
Fecal samples were obtained from the infant at 2, 9, 16, and
32 days, and 2, 6, and 12 months after birth (Figure 1). E.
coli lineages were identified by morphological and biochemical
characteristics as well as subsequent confirmation by PFGE and
random amplified polymorphic DNA (RAPD) typing. The two
main lineages were designated “A” and “B.” E. coli lineage A was
recovered at all the sampling time points and lineage B was only
transiently present in the samples collected from day 9 to 32
days of age (Karami et al., 2007; Figure 1). At 11 days of age,
a UTI infection was diagnosed and trimethoprim administered
intravenously (i.v.) for 5 days. However, due to the subsequent
presence of enterococci in addition to E. coli, the antibiotic
treatment was changed to i.v. ampicillin for 5 days followed by
oral amoxicillin treatment for an additional 8 days. Lastly, the
infant was administered trimethoprim prophylactically for the
following 7 months (Figure 1).
Transfer of an Antibiotic Resistance
Plasmid between Two Distinct E. coli
Lineages Co-Colonizing the Infant Gut
We sequenced the genomes of the E. coli isolates, obtained
from the fecal and urine samples of the infant, which
confirmed the lineages previously identified via RAPD and
PFGE typing. Comparing the genomic similarity of the two
lineages revealed that the lineages did indeed originate from
two different strains; with the initial isolate of lineage A
(4.91Mb) sharing only 77% of lineage B’s (5.45Mb) genomic
content.
To assess the genomic divergence of the individual lineage A
isolates, during the sampling period, a SNP-based phylogenetic
tree was constructed (Figure 2, Table S1). Only one SNP was
found when comparing the genomes of lineage A isolates
collected at 2, 9, and 16 days to the UTI isolate (Figure 2). Given
the very high sequence similarities between these isolates, lineage
A colonizing the gut microbiota was assumed to be the cause of
the UTI.
From the annotated genomes of lineage A and lineage B
isolates, we identified several factors that could contribute
to the pathogenicity of these strains. The genome of the
uropathogenic lineage A encoded the type 1 fimbriae FimH
among other adhesion factors (AidA-I and yqi encoded
adhesions), siderophore (enterobactin and yersiniabactin)
transporters and hemin receptors (TonB-system) as well as
enterotoxins (senB and vat) and Hemolysin E. Although the
lineage B isolates did not cause infection, its genomic content
reveals similar virulence factors such as the type 1 fimbriae
(fimH), serum survival factors (iss) and iron acquisition
(aerobactin synthesis and transport), but no enterotoxins.
While no SNPs were detected in the three isolates from lineage
B, we report the sequence of pNK29, a 42.2 kb TEM-1b encoding
conjugative IncX plasmid, that transferred from lineage A to
lineage B in situ of the gut (Karami et al., 2007; Figure S1,
Table S2). This plasmid was first detected in lineage B at 32 days,
and coincided with high resistance toward ampicillin compared
to earlier isolates (Figure 1). Similar conjugative plasmids of the
IncX family are prevalent in pathogenic E. coli, as well as other
Enterobacteriaceae isolated from humans and animals, playing
an important role in the dissemination of antibiotic resistance
genes (Norman et al., 2008; Toro et al., 2014).
Karami et al. reported an increase in lineage A counts from
106.4 CFU/g fecal matter to a density of 1011 CFU/g as the infant
was switched from trimethoprim to ampicillin and amoxicillin
treatment during the UTI infection from day 16 to 32 (Karami
et al., 2007). Such events can increase population size, and thus
the probability of plasmid transfer and enrichment of pNK29
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FIGURE 1 | Resistance profiles of co-existing E. coli lineages during the course of a urinary tract infection and antibiotic treatment. E. coli isolates were
obtained during the first 12 months of an infant’s life. At 8 days of age, the infant was admitted to the hospital due to a urinary tract infection from which the lineage A
clone was isolated at day 11. After 5 days of i.v. trimethoprim the treatment was switched to 5 days of i.v. ampicillin followed by an additional 8 days of oral (p.o.)
amoxicillin. Trimethoprim was administered to prevent reoccurring infections for the following 7 months. Along the course of treatment, lineage B acquired a TEM-1b
encoding IncX plasmid from lineage A; rendering both lineages resistant to the β-lactam treatment at day 32.
bearing cells. A similar increase in population counts from 103.9
to 1010.3 CFU/g was observed for lineage B as a result of pNK29
acquisition and antibiotic selection (Figure 1).
Interestingly, pNK29-bearing lineage B isolates were no longer
detected in the subsequent samples collected after cessation
of amoxicillin treatment (Figure 1). Plasmids often impose a
fitness cost upon first encounter with new host backgrounds
which could render lineage B less fit in the absence of selection
(Porse et al., 2016). Measuring the in vitro competitive fitness of
the initial plasmid-carrying lineage B isolate revealed a burden
of carriage (−4.9%, sd ± 4.1%, P = 0.046); indicating that a
counterselection of linage B, due to plasmid invasion, might have
taken place after discontinuation of amoxicillin treatment.
Major Genomic Events of Lineage a during
Gut Colonization
Apart from the pNK29 plasmid, all isolates of lineage A carried
a large virulence plasmid, designated pNK29-2, which was
detected throughout the year of sampling. In addition to these
two large plasmids, a novel plasmid-element was detected in
the 6 m2 and 12m isolates (Figure 2). This small (2,545 bp)
cryptic plasmid was termed pNK29-3 and had a low GC content
of 33.4%. Two open reading frames were identified on the
plasmid, which encode putative mobilization and replication
proteins (Figure S2). By comparing the coverage depth of the
plasmid to the average coverage depth of the genome, we
estimate the copy number to be around nine plasmids per cell.
BLAST-analysis revealed a high resemblance to the pIGMS31
previously isolated from Klebsiella pneumoniae as well as pEA1
(DQ659147.1) isolated from a Brazilian Pantoea agglomerans
strain (Figure S2; Smorawinska et al., 2012; Carattoli et al.,
2014). It was shown that while pIGMS31 can be mobilized to
Alpha- and Gamma-proteobacteria, it replicates via a rolling
circle mechanism that functions in Gammaproteobacteria only
(Smorawinska et al., 2012). Therefore, pNK29-3 likely originates
from other Gammaproteobacteria constituents of the gut flora.
Coinciding with the acquisition of pNK29-3 by lineage A,
the 6 m2 and 12m isolates of lineage A were also missing
∼54 kb of their chromosome compared to the previous isolates.
Annotations and flanking attR and attL sites of this region
suggested that it was an integrated phage. Using the PHAST
server and BLAST searches against NCBI GenBank, we detected
a high similarity to the Siphoviridae prophage of E. coli strains
FH199 and UMNK88 (Zhou et al., 2011). Losing this prophage
did not alter the resistance profile of the strain, but might
have been a result of negative selection imposed by increased
excision activity as a consequence of the cellular stress imposed
by antibiotic exposure (Beaber et al., 2004).
Lineage a Harbored a Highly Disseminated
and Stable Virulence Plasmid
The pNK29-2 plasmids of lineage A displayed very high sequence
identity to several widely disseminated plasmids deposited in
NCBI’s Genbank (Figure 3). Interestingly, 12 highly similar
plasmids were previously isolated from various pathogenic E.
coli strains and one originated from Klebsiella pneumoniae. In
particular, the endemic pUTI89 plasmid was found to have only
7 SNP differences to the pNK29-2 plasmid, and aligning the
contigs from this plasmid showed that there were no additional
insertions (Chen et al., 2006). Only two of the SNPs lead to
non-synonymous changes. These are located in the rsvB gene, a
resolvase, and in the traE gene, a conjugal transfer protein for F
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 5 April 2017 | Volume 7 | Article 126
Porse et al. Escherichia coli Genome Dynamics
FIGURE 2 | SNP tree and genomic events of lineage A. Branch-numbers
show the amount of SNPs separating the isolates obtained from 2 days to 12
months after birth. The majority of samples were isolated during hospitalization
and prophylactic treatment. No SNPs were detected between the isolates
collected at days 2, 9, and 16, and only one SNP (in the blaTEM1b promoter)
was detected between these isolates and the isolate collected at 32 days. Two
isolates were included at the 2 months sampling point (2 m1 and 2 m2) and
these shared 5 SNPs in common compared to the 32 days isolate. Two 6
month isolates were also included. The infant was subjected to antibiotic
treatment from day 11 to 8 months after birth. Apart from SNP differences one
sub-lineage had undergone major genomic changes by means of
chromosomal deletions and acquisition of new plasmid DNA.
pilus assembly (Table S3). We tested the ability of pNK29-2 to
conjugate to E. coli MG1655, in liquid and on solid media, and
we did not detect any transconjugants; implying that the mutated
traE transfer gene is dysfunctional in pNK29-2.
pNK29-2 Resembles Virulence Plasmids
Found in a Diverse Set of Pathogenic E.
coli
The E. coli strain UTI89, harboring the pUTI89 plasmid, is an
archetypical uropathogenic E. coli (UPEC) strain isolated from a
patient with an acute bladder infection (Mulvey et al., 2001). The
pUTI89 plasmid belongs to the IncFIB/IIA incompatibility group
and shares several characteristics with the F-plasmid including
a full tra operon for conjugative transfer (Chen et al., 2006).
Additionally, its core backbone includes stability mediating genes
such as the ccdA-ccdB toxin-antitoxin system and the stbAB
operon ensuring stable inheritance upon cell division (Cusumano
et al., 2010). Several of the lesser conserved plasmid regions
can be related to virulence and overall adaptation to the human
host. These encode the enterotoxicity (senB), copper tolerance
(scsC/scsD) and iron acquisition factors. The cjrABC operon
encodes proteins involved in iron transport that also cause
sensitivity to colicin and has shown involvement in UTI virulence
(Smajs and Weinstock, 2001; Cusumano et al., 2010).
While a majority of the bacterial hosts carrying these virulence
plasmids is associated with UTIs, extremely similar plasmids
have been isolated across E. coli patho- and sequencetypes
from all over the world (Figure 3). For example, the prototype
neonatal meningitis E. coli strain RS218, isolated in 1974, carries
a virulence plasmid virtually identical to pUTI89 and pNK29-
2, which has been shown to play an important role in its
pathogenicity (Wijetunge et al., 2014).
Likewise, the genomic backgrounds hosting these plasmids
are diverse (Figure 3) and include strains of the dominating
extraintestinal pathogenic E. coli ST131 of major clinical
importance (Stoesser et al., 2016). The geographical locations
where these strains have been isolated varies, with highly similar
plasmids isolated from different strains in the US, Japan, Canada,
and Sweden, suggesting that these pUTI89-like plasmids are
globally disseminated in a non-clonal fashion (Figure 3).
Plasmids Similar to pNK29-2 Carry
Antibiotic Resistance Genes Obtained from
Independent Insertion Events
Although these plasmids share substantial homology, some show
variation within defined but variable “genetic load” regions of
their plasmid backbone (Figure 4).
Antibiotic use is a strong selection force and some of
the plasmids similar to pNK29-2 encode one or more,
antibiotic resistance genes organized among mobile element
associated cassettes. For instance, the p1ESCUM and pKPN-7c3
plasmids have acquired the tetA gene, conferring tetracycline
resistance, at different positions within their genetic cargo
region, but associated with the same mobile elements (Figure 4;
Johnson et al., 2016). pMVAST0167_1 and pECO-fce encode
multiple antibiotic resistance genes from their genetic load
region and share a TEM-1b gene in the same location and
accommodate a similar integron with genes conferring resistance
toward aminoglycosides (aadA5), sulphonamides (sul1) and
trimethoprim (dfrA17). Compared to pMVAST0167_1, pECO-
fce encodes several additional resistance genes (sul2, tetA, strA,
strB, and tmrB) from a cassette inserted between the TEM-1b
gene and the int1 integron (Figure 4).
pNK29-2 Confers a Fitness Cost to its Host
In vitro
While the pNK29 plasmid, encoding the TEM-1b β-lactamase,
was strongly selected for during the β-lactam treatment
administered here (Karami et al., 2007), it is not obvious how
large virulence plasmids persist in the gut. The lineage A strain
persistently colonized the gut for the entire duration of the study,
from 2 days to 1 year after birth, suggesting that it is well adapted
to the human host. Such long term survival could be supported by
general persistence factors of UPEC strains, suggesting an overlap
between UTI virulence and gut persistence factors (Nowrouzian
et al., 2005; Chen et al., 2013). Only minor selection is required
for a plasmid to survive if it does not impose a significant fitness
cost on its host. We used antibiotic resistance markers to tag
the plasmid and the host chromosome of lineage A in order to
separate the plasmid-bearing variant from the cured variant and
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FIGURE 3 | Overview of plasmids resembling pNK29-2 and their host phylogeny. Thirteen plasmids with high similarity to pNK29-2 were downloaded from
Genbank (see Table S4 for accession numbers and references). Info on host strain, its disease associations and geographical origin was obtained from the literature.
The “Year” column denotes the first mentioning of the host strain in the literature unless the isolation year was clearly stated. In silico MLST typing was performed and
FimH types were added to the ST131 clade highlighting their internal diversity. A core-genome based maximum-likelihood tree was constructed to illustrate the
diversity of the E. coli plasmid hosts. Node numbers are bootstrap confidence values.
FIGURE 4 | Genetic variability and conservation within similar virulence plasmid backbones. six out of the Thirteen virulence plasmids similar to pNK29-2
showed signs of major restructuring events and are illustrated here. While these plasmids show some degree of variation, they also share a conserved core of transfer
(green), stability (blue), and virulence genes (red). Mobile elements constituting inverted repeats (highlighted in orange) allow for instability of the cjrABC-containing
region exemplified in pSaT040 and pECO-bc6. Additional genes involved in antibiotic resistance have been inserted upstream the fully conserved iron acquisition
cluster of the genetic load region in p1ESCUM, pMVAST0167_1, pKPN7c3, and pECO-fce. The TEM-1b and tetA genes are highlighted in cyan and light green
respectively. pECO-fce is significantly larger than the remaining plasmids due to a duplication of its transfer region which has been condensed for simplicity. Colored
shades illustrate BLAST identity of pairwise comparisons and orange shades highlight inverted regions.
detect plasmid loss as well as transfer events. We used markers
previously used for tagging in similar fitness experiments, where
they did not impose a measurable cost (Chen et al., 2013).
Similarly, we also confirmed that the Sh ble Zeocin resistance
gene, used for plasmid tagging, did not impose a significant
cost during 5 days of competitive growth against the non-tagged
variant (two sample t-test, P = 0.11).
The cured and plasmid bearing strains were mixed in equal
proportions and propagated in LB medium for 8 days without
selection. From CFU quantifications on selective agar plates, the
average in vitro fitness cost of the plasmid-carrying strain was
measured to be 0.92 sd ± 0.25% per generation. Although this
cost of plasmid carriage is low, one would expect a steady decline
of the plasmid bearing cells under these growth conditions.
Due to the presence of putative iron acquisition systems on
the pNK29-2 plasmid, we also tested the competitive fitness
as well as absolute growth rates in iron-limited M9 minimal
medium containing 5 µM FeCl3 mimicking the lower range of
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FIGURE 5 | Competitive growth of lineage a strain against a pNK29-2
cured variant within streptomycin treated mice. Mice where inoculated by
oral gavage with equal amounts of plasmid carrying and plasmid-free cells.
The competitive index (top left equation) is the ratio of CFUs obtained from
selective plating. This ratio was also quantified for the small intestine at the
endpoint (day 12) of the experiment to assess the potential role of adhering
cells. Replicates were excluded when the strains were no longer detected.
Significance indicators illustrate pairwise comparisons of means
(Mann-Whitney U-Test: *P = 0.014, **P = 0.0015, ***P = 0.001)
physiological concentrations (Wang, 1996). We were not able
to detect a significant advantage in terms of growth rate (Two
sample t-test, P = 0.43—Figure S3) or competitive fitness of the
plasmid carrying strain when mixed 1:1 in the same medium
(1.07± 2%, one sample t-test, P = 0.45).
The Plasmid Carrying Strain is
Outcompeted In vivo of the Mouse Gut
Because the plasmid encodes a diverse set of factors thought
to be involved in iron acquisition, toxin production as well as
several hypothetical proteins, that might be selected for in more
complex in vivo settings, we set out to test the competitive
fitness in a gut environment of streptomycin treated mice. The
plasmid-cured strain was competed against its plasmid-carrying
ancestor in the mouse gut and we measured the proportion
of plasmid-carrying to plasmid-free cells in the feces over the
course of 12 days (Figure 5). Here, we observed a steady decline
in plasmid-carrying cells compared to plasmid-free cells with
the plasmid-free cells dominating the average population after
7 days of direct competition. Interestingly, the plasmid-carrying
populations avoid complete out-competition by plasmid-free
cells in this time-span (Figure 5).
To investigate whether the measurements obtained from feces
were representative of the intestinal contents, including cells
adhering to the intestinal wall, we measured the proportion of
plasmid-bearing cells sampled directly from the small intestine
of the mice at the end of the 12 days experiment. There was no
significant difference between the direct sampling compared to
fecal counts (Mann-Whitney U-Test, P = 0.27) and >10% of the
cells contained the plasmid in the average replicate population at
this stage (Figure 5).
From the competition experiment we calculated the average
fitness cost per generation of the plasmid in the mouse gut to be
0.83 sd± 0.2%, assuming that the competing E. coli underwent 10
generations per day (Rang et al., 1999; Lee et al., 2010; Myhrvold
et al., 2015). This cost is slightly lower, but not significantly
different, from the plasmid cost measured in vitro (Two sample
t-test: P= 0.61).
pNK29-2 is Stably Inherited Despite its
Cost
Although the plasmid-bearing strain is less fit than the
plasmid-cured variant in vivo, it seems possible that a minor
subpopulation of plasmid-bearing cells can persist for extended
time periods; especially if competition from plasmid-free
daughter cells is postponed via stable inheritancemechanisms. As
for all the virulence plasmids analyzed here (Figure 3), pNK29-
2 carries the highly conserved stbAB stability operon (Figure 4)
that encodes active segregation machinery; ensuring that the
plasmid is stably segregated to both daughter cells during cell
division (Guynet et al., 2011). To test the segregational stability of
pNK29-2 in its native lineage A host (day 0 isolate), we conducted
14 days of serial passaging in LBmedium, corresponding to∼140
generations of growth. In such a setup, plasmid-free segregants
would eventually take over the population due to the cost of
plasmid carriage. However, we did not observe any plasmid-free
cells within this time span with a detection limit of plasmid-free
cells of∼1%. Similarly, no plasmid-free cells were detected in the
in vivo competition assays, during the 12 days of gut colonization.
Taken together, these results imply that virulence plasmids,
such as pNK29-2, have no direct advantage in gut colonization
but are able to persist in spite of a small, but significant, fitness
cost due to efficient plasmid inheritance mechanisms.
DISCUSSION
Culture independent methods based on metagenomic
sequencing have been used to investigate the abundance
profiles of strains colonizing the gut over time (Morowitz et al.,
2011; Brown et al., 2013; Sharon et al., 2013). However, these
methods are limited in their ability to observe genomic events at
high resolution such as horizontal transfer and single nucleotide
variations.
Due to our longitudinal sampling and the high resolution
of single isolate genome sequencing, we were able to observe a
glimpse of the complex genome dynamics of E. coli in its native
settings. We confirm a gut-inhabiting strain as the origin of a
bladder infection; supporting the general belief that UTIs are
caused by gut inhabiting E. coli strains that eventually enters
the urethra (Chen et al., 2013). Furthermore, we report the
sequence of pNK29, a novel 42.2 kb IncX plasmid carrying a
TEM-1b β-lactamase, which was transferred between the two co-
existing E. coli lineages of the gut. Few phenotypic reports exist
documenting plasmid mediated HGT of antibiotic resistance
genes between bacteria in the human gut and our data supports
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that transfer of resistance genes take place in the gut, and
may be enhanced by antibiotic treatment (Bidet et al., 2005;
Karami et al., 2007; Trobos et al., 2009; Goren et al., 2010). The
recipient lineage was only sampled at one time-point after the
termination of β-lactam antibiotic administration (day 32) and
declined to undetectable levels thereafter. This could indicate
a negative selection of pNK29-carrying lineage B isolates in
the absence of antibiotic selection; however, confirming the
role of pNK29 in the counterselection of lineage B in the gut
will require further in vivo competition experiments. Lineage B
showed a large drop in population counts when subjected to
the first round of trimethoprim treatment upon hospitalization
(Figure 1). The prophylactic administration of trimethoprim
coincided with the disappearance of lineage B, and could be
another likely explanation for its absence in the consecutive time
points.
While we did not observe any genomic alterations of lineage
B apart from the acquisition of pNK29, lineage A experienced
chromosomal deletions and acquired a cryptic plasmid as well as
a high number of SNPs during the sampling period (Figure 2).
Genome plasticity is believed to play a crucial role in the
adaptation of pathogens to the selective forces imposed by the
immune system or the remaining microbiota within a human
host (Brzuszkiewicz et al., 2009). The mutation rate observed for
lineage A was high and resemble that of mutator phenotypes that
are often enriched among UPEC isolates (Labat et al., 2005). Such
increased rates of mutation and recombination events might also
be the result of antibiotic treatment of the infant; leading to
induction of the bacterial SOS response, which has been shown
to increase mutation rates (Beaber et al., 2004; Michel, 2005).
Non-synonymous mutations were indeed detected in genes
related to antibiotic tolerance, e.g., those involved in folate
metabolism (folA—targeted by trimethoprim), fusaric acid
resistance (fusB), ABC-transport and membrane permeability
(porins; Table S1). Equivalently, the genomic deletion of the
54 kb region might have resulted from antibiotic mediated stress
known to induce prophage excision and increase horizontal gene
transfer in general (Beaber et al., 2004; Nanda et al., 2015).
Apart from small cryptic plasmids providing no obvious
selective advantage to their bacterial host, gut-inhabiting E. coli
isolates often carry plasmids that allow adaptation toward the
human host by contributing virulence or antibiotic resistance
factors (Johnson and Russo, 2005). In addition to the β-lactamase
carrying pNK29 IncX plasmid, we identified a 114 kb plasmid
(pNK29-2) in lineage A that was strikingly similar to other
previously sequenced virulence plasmids from a diverse set of
pathogenic E. coli strains (Figure 3). These plasmids have been
shown to play a role in the initial stages of UTI infection in a
mouse model in a different genetic host background, and could
have provided lineage A with the necessary virulence factors
leading to the successful UTI infection observed in the studied
infant. Although it is generally believed that specific pathotypes
of E. coli carry different virulence plasmids, plasmid backbones
virtually identical to pNK29-2 have recently been found in K.
pneumoniae as well as several divergent E. coli strains; with
the earliest isolate dating back to 1974 (Figure 3). The high
conservation of these plasmids suggests that they provide a
universal adaptive benefit to their ExPEC hosts regardless of
infection site (Johnson and Nolan, 2009; Cusumano et al., 2010;
Wijetunge et al., 2014).
When comparing the genetic composition of the currently
sequenced virulence plasmids with high similarity to pNK29-2,
it is clear that certain regions tend to preserve genetic features
across host, geography and time (Figures 3, 4). These include
mediators of iron acquisition, toxin production and putative
copper resistance mediators (scsC and scsD; DebRoy et al.,
2010). Carrying genes implicated in virulence, these plasmids
could confer a survival advantage to their bacterial host during
infection. Prior studies have examined the role of pUTI89 and
pRS218 in urinary tract infections and neonatal meningitis,
respectively (Cusumano et al., 2010; Wijetunge et al., 2014).
These studies did not observe any phenotypic differences in vitro
between the plasmid bearing and cured host in terms of growth
rate, type 1 pilus expression or biofilm formation. However,
they did observe a significant difference in infectivity using
rodent infection models (Cusumano et al., 2010; Wijetunge et al.,
2014).
A vital defense mechanism of the human body is to restrict
iron from pathogens, thus acquisition and transport of iron is
an important survival mechanism for ExPEC strains in vivo
(Andrews et al., 2003). Therefore, iron acquisition could be
beneficial for survival in many niches of the human body,
including the densely populated gut microbiota, where access
to iron is limited (Andrews et al., 2003; Nowrouzian et al.,
2003). While Cusumano et al. speculated that the cjr operon of
pUTI89 was beneficial in a UTI infection scenario due to its
putative involvement in iron acquisition, we could not detect
an advantage in neither absolute growth rate nor competitive
fitness of lineage A carrying the pNK29-2 plasmid when grown
in iron-limited conditions (Cusumano et al., 2010). Although
the effect was small or non-existent in our experimental setups,
pNK29-2 might provide an advantage by other means. For
example, the pNK29-2 genes encoding siderophore receptors or
transporters might provide an advantage, only if the available
iron is on a certain form e.g., bound by its respective
siderophore. As other iron acquisition systems are located on
the chromosome of lineage A, the pNK29-2 encoded systems
could be redundant in this strain, but might be selected in
other hosts to encourage plasmid maintenance in a communal
context.
Previous studies have shown that even minor differences
in host genomes can be highly influential in determining
plasmid establishment as well as subsequent adaptation and
long term persistence (Humphrey et al., 2012; Porse et al.,
2016). Thus, it is intriguing that virulence plasmids imposing
a minor, but significant, fitness cost without providing any
strongly selected phenotypes, can persist in a competitive
environment such as the human gut. From our in vivo
competition experiment, it is clear that the pNK29-2 carrying
strain was less fit in the murine gut but does reach stable counts
from day 7 to 12 (Figure 5). This stagnation in competition
could encourage extended plasmid persistence and might be
explained by changes in the growth rate of gut inhabiting
strains over time; indicating a non-constant selection pattern
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(Rang et al., 1999). Such selection patterns are known to
occur in mixed bacterial populations encompassing social iron
acquisition phenotypes and similar dynamics could take place
in the competition between pNK29-2 carrying and plasmid-free
strains in the gut (Stojiljkovic et al., 1993; Ross-gillespie et al.,
2007). However, this does not seem to be the case from our
growth rate measurements in iron-limiting conditions, were the
plasmid carrying strain did not have an advantage on its own
(Figure S3).
The measured fitness cost of the pNK29-2 in the lineage
A strain was surprisingly similar between in vitro and in
vivo setups, and is low compared to previous observations of
plasmid costs (Vogwill and MacLean, 2015). While plasmids
can in theory compensate their loss and fitness cost by re-
infection of plasmid-free hosts (Slater et al., 2008), this is
unlikely to be the case for pNK29-2 as we did not observe any
transconjugants in our in vitro conjugation assays nor during
the in vivo competition experiment. The inability of plasmids
to conjugate might be explained by the fitness constraints a
functional conjugation machinery can impose on certain hosts;
supported by the existence of plasmid variants, such as pCE10A
from Lu et al., lacking the conjugative transfer operon, that are
otherwise identical to pNK29-2 (Lu et al., 2011; Porse et al.,
2016).
Loss of pNK29-2 was not observed, neither in vivo nor in
vitro, suggesting that primary stability mechanisms such as active
segregation and toxin-antitoxin systems are the most important
persistence parameters for these plasmids. This is consistent with
the high degree of conservation of stability systems among all 14
plasmids examined here and further supported by the fact that
we, as well as previous studies, have experienced considerable
trouble curing strains from these plasmids; unless the stbAB
operon is disrupted (Cusumano et al., 2010; Wijetunge et al.,
2014).
By characterizing the genomes of persistent lineages of E.
coli colonizing the gut of an infant, we observed substantial
dynamics, highlighting that strains colonizing the human gut
undergo continuous change. While genomic plasticity can lead
to improved persistence, some elements are surprisingly stable.
Our cost and stability characterizations suggest that a low cost
and a high segregational stability, combined with plasmid-
encoded universal virulence factors, presumed to increase fitness
in a broad range of infection scenarios (Cusumano et al.,
2010; Wijetunge et al., 2014), are likely the main parameters
governing the success of endemic virulence plasmids. Further
understanding of the factors contributing to genomic variation
of gut colonizing pathogens will aid in rational interventions
against the virulence and antibiotic resistance determinants
widely disseminated among these isolates.
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Figure S1 | Plasmid map and BLAST comparison of pNK29. pNK29
compared to IncX1 plasmids pOLA52 (outer ring, green) and
pRPEC180_47(middle ring, blue). Open reading frames are drawn directionally
(inner ring, black). Selected annotations are labeled outside the ring (see Table S2
for full annotation list).
Figure S2 | Plasmid pNK29-3 compared to most similar plasmids in
GeneBank. The two ORFs encode putative replication and mobilization proteins
and open reading frames are drawn directionally (inner ring, black).
Figure S3 | Growth rate of lineage A with and without pNK29-2 under
iron-limited conditions.
Table S1 | SNPs in different isolates of lineage A. Table containing the SNPs
from lineage A, including the annotation and whether the animo acid change was
synonymous or non-synonymous. The isolates from days 2, 9, and 16 are left out
as they did not have any SNP differences from the representative genome for the
lineage (isolate taken at 2d).
Table S2 | Annotations for pNK29. Names in square brackets indicate
homologs in pOLA52.
Table S3 | SNPs in the pNK29-2 plasmid of lineage A compared to pUTI89.
SNPs were identified by comparing the initial linage A isolate (day 2) with pUTI89
(CP000244.1).
Table S4 | Plasmids similar to pNK29-2 and information on their origin.
The table presented in Figure 3, but more detailed information on size,
location, and references. The GenBank ID refers to the plasmid sequence
entry in GenBank and the Pubmed ID (PMID) to the study where the plasmid
was initially described.
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